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During the past few years, the field of tissue engineering (TE) has been shifting from replacement to
regenerative strategies. Following this tendency, the requirements for biomaterials to be used in TE
have been also changing. While a few decades ago bioinert materials that do not provoke undesired
body responses were in the focus of material sciences, nowadays third generation biomaterials
mimicking the nanoscale mechanisms of the interactions between cells and their in vivo environment are
the target of material design. Although these mechanisms involve different bioactive molecules, until
now mainly strategies involving small peptide epitopes that copycat specific sequences of complex
proteins have been exploited. The breakthroughs that such approaches brought to biomaterials and TE
fields are undeniable. Nevertheless, the important role that carbohydrates play in tissue structuring and
function is still poorly explored and exploited in this context and we believe that this is one of the
missing pieces in the TE puzzle. Carbohydrates are an integral part of our life. We are literally covered
by them: from bacteria to mammalian cells, the molecular landscape of the cell surface is coated with
sugars forming the so-called glycocalyx. This strategic placement of the sugars makes them crucial for
the development, growth, function and/or survival of an organism. It is believed that the structural
diversity of carbohydrates is the key for understanding and controlling those processes because of the
huge number of ligand structures, which sugars can display in molecular recognition systems. However,
their main advantages: the intricacy and the large natural diversity have turned against the scientists
and have hampered their study. As a result, the field of glycomics is much less developed compared to
its counterparts genomics and proteomics within TE. Recent advances in carbohydrate synthesis,
sensing technologies and processing methodologies are inducing rapid changes in this field and will be
discussed in this paper. The use of carbohydrates as an interrogation and modulation tool for better
understanding of the complexity and dynamics of the natural three-dimensional environment of the
cells will be also focussed.
Introduction
The field of tissue engineering (TE) exploits living cells and
biomaterials in a variety of ways to restore, maintain, or enhance
tissues and organs.1 During the 1960s and 1970s, it was believed
that the biomaterials used must be bioinert and thus minimising
the body’s response to foreign devices.2 About ten years later,
this view was changed and second generation3 bioactive materials
that elicit a controlled action and reaction in a physiological
environment had emerged. With the development of nano-
biotechnology, the researchers have learnt from Nature about
the structure and properties of living tissues and systems.
Nowadays, it is well known that cells can sense, integrate and
respond to environmental cues. This understanding brought the
third generation biomaterials4 able to cross-talk with cells and
biomolecules from the physiological milieu and thus stimulating
specific cellular responses at the molecular level. The strategic
placement of oligosaccharides and glycoconjugates on the cell
surface makes them a key element of this communication
process. However, for many years the chemistry and biology of
carbohydrates have been considered as a Cinderella field5: an
area that involves tremendous work but stays in the shadow of
her cousins genomics and proteomics. Initially, carbohydrates
were only seen as structural components of natural products
or as a source of energy. Only in the late 1980s, the field of gly-
cobiology emerged as an attitude integrating the traditional
carbohydrate chemistry and biochemistry with a modern
understanding of the cell and molecular biology of glycans and
their conjugates with proteins and lipids.6,7 Hence, carbohydrate
research has become a hot subject only after the scientists
understood that the functions of cells and organisms cannot be
explained by protein and nucleic acids alone. Once viewed as
a hydrophilic heterogeneous nuisance to be removed from the
cell surface or secreted proteins of interest, oligosaccharides have
been recognised as an intricate network encoding a wealth of
information. Nowadays, their key participation in the intercel-
lular communication, various recognition processes and signal
transduction events (Fig. 1) is confirmed. However, the precise
mechanism of many of those processes remains to be elucidated
and though potential opportunities exist, the pace of develop-
ment of carbohydrate research has been slower than the ones of
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proteins and nucleic acids. This embarrassing fact is in large part
due to their inherent structural complexity, the great difficulty in
determining their sequences, and the fact that their biosynthesis
could not be predicted directly from a DNA template, i.e. their
genetic manipulation is far more complicated than for proteins
and nucleic acids.
In 2003, glycomics, the systematic effort to understand the
biosynthesis, structure and function of carbohydrate polymers
and oligosaccharides, was included8 in the list of the 10 emerging
technologies that will change the world. In fact, this past decade
was marked by tremendous breakthroughs in this field: we have
witnessed the development of the first automatic carbohydrate
synthesis and the first trials with and on carbohydrate arrays.
These recent advances have provided critical material for bio-
logical investigations, which resulted in discoveries of new
bioactive carbohydrates and revealed the great potential of
oligosaccharides in the field of TE and as therapeutics preventing
virus and bacterial infections or retarding cancer progress.
The complexity of carbohydrates
The complexity of carbohydrates has been attracting the atten-
tion of researchers from different scientific fields for more than
a century (Table 1). Since Emil Fischer determined the stereo-
chemistry of their building blocks, the monosaccharides, up to
today scientists are seeking to understand the Nature’s choice of
certain carbohydrates and her ways of producing, manipulating
and employing them.
What makes carbohydrates that unique and what distinguishes
them from the other two classes of biomacromolecules, proteins
and polynucleotides, responsible for the information transfer
in the biological systems? Unlike proteins and polynucleotides,
saccharides are not direct genetic products. Instead, they are
synthesised by complex pathways, regulated by multiple factors
including metabolic levels of sugar nucleotides, expression and
localisation of glycosylation enzymes, and protein-trafficking
mechanisms. As a result, carbohydrates differ from other bio-
logical macromolecules in two important characteristics: they
can be highly branched molecules and many different linkages
can bind their residues. For example, any pair of six-carbon
monosaccharides can be linked in 11 different ways (Fig. 2).
Assuming that ten distinct types of monosaccharides are
commonly available in mammalian tissues9 (Table 2), the
formation of 10 ! 10 ! 11, or 1100 different disaccharides is
theoretically possible. In comparison, two amino acids can be
joined in only one way, creating 202 dimers and the possible
combinations for the nucleotides are only 42 or 16 dinucleo-
tides.9–11 The number of possible combinations rapidly increases
with each additional monosaccharide and outpaces those for the
respective peptides and oligonucleotides. Usually, saccharide-
binding proteins recognise hexaoligomer or smaller oligosac-
charides. Based on this fact and on seven major structural
features of carbohydrates: (i) epimers, including D and L forms;
(ii) linear sequence of core and linear branches; (iii) ring size;
(iv) anomeric configuration; (v) linkage position; (vi) branching
positions and (vii) reducing terminal attachment, Laine calcu-
lated12 that the theoretical number of all possible linear and
branched isomers of a hexasaccharides is >1.05 ! 1012. There-
fore, in a short sequence of carbohydrates can potentially display
a huge number of ligand structures to the binding sites of
proteins in molecular recognition systems. Thus, their potential
to encode information in a short sequence is several orders of
magnitude higher than that of any other biological macromole-
cule.11 Because of this potential, carbohydrates are called the
third alphabet13 of the language of life (behind nucleic acids
and proteins): they are like the accents on spoken words – they
change the meaning without changing the spelling!
Moreover, we must consider two other issues when speaking
about the complexity of the carbohydrates: (i) in a mono-
saccharide unit, some or all of the hydroxyl groups can be
replaced by phosphonic or sulfonic groups (e.g. glycosamino-
glycans) and (ii) in a cell organism, the oligosaccharides are
usually attached to another molecule forming so-called glyco-
conjugates, which include glycoproteins, glycolipids and glyco-
sylphosphatidylinositol (GPI) anchors. Given this potential
structural diversity of carbohydrates, how complex is the gly-
come really? In fact, the number of structural combinations
encountered in nature has not yet been elucidated. A recent
report by Seeberger et al.9 focuses the analysis of structural
complexity of mammalian oligosaccharides actually found in
nature (carbohydrates database). This report demonstrated that
a rather limited set of the theoretically possible building blocks is
sufficient to access the majority of the mammalian glycospace;
just 11 monosaccharide connections account for >75% of all
linkages and only 36 building blocks are required to construct
75% of the studied 3299 mammalian oligosaccharides. Unfor-
tunately for the glycoscientists, the bacteria glycome is much
complex, composed by many more building blocks that are
connected in a dazzling array of branched structures.14 So far, it
has not been shown how and why the Nature chooses these
blocks. These questions have been addressed for many years but
they are still difficult to be answered since the great majority of
glycans in nature are yet to be discovered and structurally
defined.
Biological roles of carbohydrates
For the past decades, a variety of theories have been presented
regarding the biological roles of the carbohydrates.7,15,16 It
appears that glycans span a large spectrum of bioactivities: from
those that are trivial such as source of energy or pure structural
role to those that are crucial for the development, growth,
function or survival of an organism. This variety is not surprising
if one keeps in mind their structural diversity. Moreover,
Fig. 1 Participation of cell surface carbohydrates in recognition
events with another cell (A), toxins (B), viruses (C), antibodies (D) and
bacteria (E).
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carbohydrates have very strategic location on the cell surface
(Fig. 3). From bacteria to mammalian cells, the molecular
landscape of the cell surface is coated with sugars (so-called
glycocalyx), which makes them the first points of contact
between cells and their environment. The sugars placed on the
cell surface can either build a protective layer from harmful
physical forces or regulate interactions of cells with the envi-
ronment. Thus, they are in a position to modulate or mediate
a plethora of biological processes in cell-cell, cell-matrix, and
cell-molecule interactions. Therefore they have a great potential
in the TE field as bioactive agents able to control the develop-
ment and function of a complex multicellular organism.17 The
Table 1 Some of the most important advances in the elucidation of the complexity of carbohydrates. A detailed table is available elsewhere7
Year Discovery Main scientists involved
1891 Monosaccharide’s stereoisomers H. E. Fischer
1916 Isolation of heparin as an
anticoagulant
J. MacLean
1925 Characterisation of chondroitin
sulfate and mucoitin sulfate
P. A. Leven
1929 Pyranose and furanose ring
structures of monosaccharides
W. N. Haworth
1934 Hyaluronan and hyaluronidase K. Meyer
1934–1938 Sialic acid G. Blix, E. Klenk
1942 Gangliosides in brain E. Klenk, G. Blix
1948–1950 Occurrence of N-sulfates in heparin
and identification of heparin
sulfate
E. Jorpes, S. Gardell
1952 Sialic acid as the receptor for
influenza virus
A. Gottschalk
1956–1963 Bacterial peptidoglycan backbone
structure major structural
polysaccharides in nature
(chitin, cellulose) are b1-4-linked
throughout
M. R. J. Salton, J. M. Ghuysen, R.
W. Jeanloz, N. Sharon, H. M.
Flowers
1958 Mucopolysaccharides are
covalently attached to proteins
via serine
H. Muir
1960–1965 Structure of lipopolysaccharides
and endoxin glycans
O. Westphal, O. L€uderitz, H.
Nikaido, P.W. Robbins
1960–1970 Structural studies of
glycosaminoglycans
R. Jeanloz, K. Meyer, A. Dorfman
1962 GlcNAc-Asn as the first defined
carbohydrate-peptide linkage
A. Neuberger, R. Marshall, I.
Yamashina, L.W. Cunningham
1962–1966 Identification of tetrasaccharide
linking glycosaminoglycans to
protein core of proteoglycans
L. Roden, U. Lindahl
1963 Analysis and nomenclature of
gangliosides
L. Svennerholm
1963–1965 Structure of GM1 and other brain
gangliosides
R. Kuhn, H. Wiegandt
1968 Description of the domain
structure of heparan sulfate
J.A. Cifonelli
1969 Structures of O-glycans from
erythrocyte membranes
R.J. Winzler
1969–1974 Hyaluronan-proteoglycan
interactions in cartilage
V.C. Hascall, S.W. Sajdera, H.
Muir, D. Heineg"ard, T.
Hardingham
1973 A common pentasaccharide core
structure of all N-glycans
J. Montreuil, R.G. Spiro, R.
Kornfeld
1975 The first galectin V.I. Teichberg
1975–1980 N- and O-glycan structural
elucidation using multiple
convergent techniques
A. Kobata
1977 Cell-surface glycans as attachment
sites for infectious bacteria
I. Ofek, D. Mirelman, N. Sharon
1980–1983 Structure of polysialic acids in
bacteria and vertebrates
F.A. Troy, J. Finne, S. Inoue, Y.
Inoue
1980–1982 Mass spectrometry for structural
analysis of glycans
V.N. Reinhold, A. Dell, A.L.
Burlingame
1981–1985 Structural definition of
glycosylphosphatidylinositol
(GPI) anchors
M.J. Ferguson, I. Silman, M. Low
1986 Structures of sulfated N-glycans of
pituitary hormones
J.U. Baenziger
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mediation of the above mentioned processes can be achieved via
different ways18,19: some of the sugars act as classical ligands or
co-receptors that facilitate cell attachment and mediate signalling
(e.g. glycosaminoglycans of the mammalian cell surface serve
as co-receptors for proteins that affect the respective cell, while
others act indirectly by regulating interactions of molecules via
steric hindrance, exclusion or recruitment. The flexible nature of
the sugars in a glycoprotein allows for many more confirmation
than would their purely protein amino-acid counterparts. Thus,
sugars can promote proper folding of proteins by stabilising
particular conformation and in some cases protecting the protein
portion of the glycoprotein against degradative enzymes.
Alterations in cell-surface glycans are commonly observed
in a wide variety of diseases and are strongly correlated with
cancer prognosis, metastatic potential and the organ specificity
of metastasis. Moreover, strong evidence that glycan remodelling
is an integral part of disease progression has led to speculation
that carbohydrates are key diagnostic and prognostic indicators
as well as therapeutic targets of interest. Cell surface molecules
are also strategically exposed for surveillance by the immune
system allowing for the potential immune recognition of
abnormal cells. Despite those potential abilities of carbohy-
drates, the lack of tools for studying glycobiology prevented
biologists and medical researchers from addressing research
problems that involve them until very recently.20 Defining the
function of glycans in the biological milieu presents a challenge
due to the complexity of carbohydrates at the structural,
biosynthetic and functional levels.
Synthesis of oligosaccharides
Access to structurally defined carbohydrates is a prerequisite for
revealing their function and establishment of the structural
features important for this function. Carbohydrate biosynthesis
and diversification involves several complex steps.21 The assem-
bling takes place in the endoplasmic reticulum and Golgi appa-
ratus and it affords significant product microheterogeneity
(Fig. 3), which explains the difficulties in obtaining homogeneous
and chemically defined glycoconjugates from natural sources.16,22
On the other hand, carbohydrates are also challenging for
the synthetic chemists because of the many functional groups
that have to be protected in order to get one, specific group to
react. Additional complication arises from the need to control
the stereochemistry of the newly formed glycosidic linkage
(Fig. 2).
Generally, the strategies for synthesis of carbohydrates can be
divided into chemical and enzymatic ones. The chemical
approaches are formidable; typically they involve a large number
of organic reactions aiming at stereo- and regiochemical control
of the forming glycosidic linkage followed by time consuming
and expensive purification steps.23 Chemical strategies include
traditional solution-phase chemical synthesis, one-pot reactivity
based glycosylations and automated solid-phase synthesis. For
all those strategies, the preparation of selectively protected
monosaccharide units is a crucial step. These units should be
designed to present a strategically positioned free hydroxyl group
(a nucleophilic acceptor) or a labile leaving group at the
anomeric carbon that acts as a glycosyl donor. Thus, the main
advances in different chemical approaches are related with the
unveiling of anomeric groups that allow for high-yields, selective
and reliable formation of different glycosidic linkages (e.g.
Fig. 4).
The one-pot glycosylation method refers to an approach in
which several glycosyl donors are allowed to react sequentially in
the same vessel resulting in a single oligosaccharide product. The
method was proposed by Raghavan and Kahne in 199325 when
the synthesis of a-linked deoxytrisaccharide by sequential che-
moselective activation of glycosylsulfoxide and thioglycoside
using a single activator was described. Lately, numerous research
groups have been working on the various one-pot synthetic
strategies and a significant result of these efforts has been
the development of programmable one-pot synthesis.26,27 The
underlying principle of one-pot glycosylation is the ability to
control glycosyl donor reactivity. Over the years three major
concepts have emerged as main ones in this field (Fig. 5):
(i) chemoselective strategy; (ii) orthogonal glycosylation and
(iii) pre-activation strategy.28
In the chemoselective strategy (Fig. 5A), the protecting groups
are used as a tool for tailoring the reactivity of glycosyl donors:
the leaving groups in the glycosylation reaction are activated by
electron-donating groups (arm) and deactivated by electron-
withdrawing groups (disarm). The viability of this so-called
armed-disarmed concept was firstly documented by Paulsen29
and later demonstrated by Fraser-Reid et al.30 The majority of
the following studies have been qualitative until Lay’s group
initiated a breakthrough study31,32 aiming at the estimation of
relative reactivity values (RRV) of some gycosyl donors by NMR
spectroscopy. The RRVs describe the product ratio when two
donors compete for a single acceptor. Therefore, they can be
used to predict the product when multiple glycosyl donors are
present and/or to select a proper donor. An alternative route
for determination of RRVs was proposed by Wong et al.26 In
their study, they designed competition experiments with various
thioglycoside-activated glycosyl donors and donor-acceptors.
The RRVs in this case were estimated by HPLC. Based on the
created reactivity database, the OptiMer software was created
which allows search and selection of suitable building blocks for
one-pot assembly of a desired oligosaccharides or a library of
individual oligosaccharides.
Fig. 2 Possible linkages between two identical monosaccharides.
8806 | J. Mater. Chem., 2010, 20, 8803–8818 This journal is ª The Royal Society of Chemistry 2010
Do
wn
loa
de
d b
y U
niv
ers
ida
de
 do
 M
inh
o (
UM
inh
o) 
on
 11
 N
ov
em
be
r 2
01
0
Pu
bli
sh
ed
 on
 05
 O
cto
be
r 2
01
0 o
n h
ttp
://p
ub
s.r
sc.
org
 | d
oi:
10
.10
39
/C
0J
M
01
60
5E
View Online
Besides changing the protective groups, other variables such as
the nature of the anomeric leaving groups or the effect of the
solvent on the donors’ reactivity during the glycosylation process
can be also used to facilitate efficient oligosaccharide one-pot
synthesis. Thus, the orthogonal strategy (Fig. 5B) introduced by
Takahashi et al.33,34 uses various anomeric leaving groups to
tailor the reactivity of the glycosyl donors. Compared with the
chemoselective glycosylation, this strategy has an advantage: it
allows the condensation of building blocks independently of their
RRVs. In 2000 Takahashi’s group reported27 the first multistep
synthesis performed in a parallel manual synthesiser (Quest 210).
The authors described the synthesis of a library of 54 linear and
Table 2 The 10 most abundant monosaccharides (sugar ‘‘letters’’) found in mammalian oligosaccharides (data are based on the results published
elsewhere9). While nucleic and amino acids can be represented with one letter in the polynucleotides and proteins, the complexity of sugars does not
allow this representation and instead colour symbols are typically used by the glycobiologists
Name Chemical structure Colour symbola Abundance (%)b
Number of substitutable OH
groups
D-N-acetyl glucosamine
(D-GlcNAc)
31.8 3
D-Galactose (D-Gal) 24.8 4
D-Mannose (D-Man) 18.9 4
D-N-acetylneuraminic acid or sialic
acid (D-NeuAc or D-Sia)
8.3 4
L-Fucose (L-Fuc) 7.2 3
D-N-acteyl galactosamine
(D-GalNAc)
4.8 3
D-Glucose (D-Glc) 2.5 3
D-Glucuronic acid (D-GlcA) 0.3 3
D-Xylose (D-Xyl) 0.1 3
L-Iduronic acid (L-IdoA) 0.1 3
a Each monosaccharide class has the same shape and isomers are differentiated by colour.7 b The values are reported elsewhere.9
This journal is ª The Royal Society of Chemistry 2010 J. Mater. Chem., 2010, 20, 8803–8818 | 8807
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18 branched trisaccharides, which later was extended to hepta-
saccharides.35 In fact, this approach can be considered as an
initial form of the automatic oligosaccharide synthesis.
The examples given above demonstrate that reactivity-based
one-pot synthesis has greatly facilitated the glycosylation process.
However, the excessive synthetic work required to obtain building
blocks with suitable anomeric reactivities complicates the overall
procedure and decreases its efficiency. In 2004, Huang et al.
proposed36 an alternative approach of iterative one-pot synthesis
of oligosaccharides based on the pre-activation strategy (Fig. 5C).
This strategy integrates the advantages of both chemoselective
strategy (activation under a single set of glycosylation conditions)
and orthogonal strategy (independence of RRVs). The reaction
scheme involves pre-activation of glycosyl donors, which gener-
ates a reactive intermediate in the absence of acceptor. After
addition of the second building block to the pre-activated donor,
a disaccharide is formed which can be activated in the same
manner. The process can be repeated several times in the same
flask until the targeted oligosaccharide is obtained. Several
requirements need to be fulfilled in order to have an efficient
reaction28,37: (i) the activator should work with a wide range of
glycosyl donors in a stoichiometric amount and to be completely
consumed by the donor in order to prevent further activation
of the following building blocks; (ii) the generated intermediate
must be sufficiently long-living to allow the addition of the
acceptor but yet reactive enough for a high-yielding glycosyl
coupling; (iii) side products formed during the reaction should
not interfere with the glycosylation process. The obstructions
associated with the applicability of the pre-activation strategy to
the synthesis of complex oligosaccharides are related with the
breach of some of these requirements. In some cases the pre-
activated donors do not react with the acceptors and thus, an
optimisation of the coupling conditions or/and development of
more powerful activators are required. Another obstacle is related
with a side reaction: a regeneration phenomenon has been
observed occasionally when thioglycosides bear the same leaving
group. This effect can be a result from aglycon transfer and there
are several studies devoted to the resolution of this problem.38–40
Fig. 3 A schematic presentation of glycoconjugate biosynthesis, surface
expression and recognition. Only few polysaccharides are found inside
cell, while most oligo- and polysaccharides are part of the extracellular
matrix or are present on the cell surface where they either play a protec-
tive role or regulate the interactions of cells with the environment.
Fig. 4 Regioselective protection of hydroxyl groups in monosaccharides: traditional multistep approach (A) and one-pot approach proposed by Hung
et al.24 (B, OTMS ¼ O-trimethylsilyl group) which allows synthesis of 152 different glucose building blocks by only four different types of one-pot
reactions.
8808 | J. Mater. Chem., 2010, 20, 8803–8818 This journal is ª The Royal Society of Chemistry 2010
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Undoubtedly, the automated solid-phase synthesis of oligo-
saccharides developed and proposed by Seeberger’s group41 is
one of the milestones in the rapidly developing field of glycomics.
The impact of an automated oligosaccharide synthesiser can be
easily understood if one analyses the breakthroughs, which
automated peptide and oligonucleotide synthesis brought in the
field of TE, biochemistry and associated biomedical applications.
The principle is the same (Fig. 6): the growing chain of an
oligosaccharide is covalently linked to an insoluble support such
as Merrifield’s resin. Reagents are added to a suspension of the
solid support and allowed to react with or modify the reactant
attached to the support. An excess of reagents ensures the
completion of the reaction. Once the synthesis sequence is ter-
minated, all unreacted reagents or side products remaining in the
Fig. 5 Concepts for one-pot glycosylation: chemoselective strategy (A); orthogonal strategy for linear (B1) and branched (B2) oligosaccharide
synthesis; and glycosylation based on the pre-activation strategy (C).
Fig. 6 Automated oligosaccharides synthesis showing coupling, deprotection and final detachment from the solid support employed for the synthesis of
an oligo-a-mannoside bearing a pentenyl linker on the reducing end.
This journal is ª The Royal Society of Chemistry 2010 J. Mater. Chem., 2010, 20, 8803–8818 | 8809
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solution can be removed by simple filtration and washing. The
targeted product is collected after cleavage from the solid
support. As in the other synthetic strategies, the development
and use of protecting groups is pivotal for the success of the
synthetic procedure. Permanent protecting groups, such as
benzyl ethers (BnO-) are used in the positions where a free
hydroxyl will be present in the final product. Temporary pro-
tecting groups, such as esters (CH3COO-, AcO-) are used to
mask hydroxyls that will participate in the glycosylation. Besides
the use of orthogonal protective groups to assist controlled
regioselectivity and thus controlled branching of the carbohy-
drate chain, the stereochemistry of the anomeric carbon must be
also controlled. Placement of participating protective groups at
the C2 hydroxyl or amine groups ensures the formation of trans-
glycosidic linkage, whereas non-participating groups are needed
for the preferential installation of cis-glycosides.20 Another key
issue in the solid-phase synthesis is the choice of the linker to the
resin: it must remain stable during the coupling and deprotection
events but to be readily cleavable following the synthesis and
ideally to leave a spacer on the reducing end for further func-
tionalisation.42 In their works, Seeberger et al. have employed
4-octenediol linker (Fig. 6, 1) that can be cleaved via olefin cross-
metathesis in the presence of Grubbs catalyst and ethylene.41
As in the strategies described above, the automated oligosac-
charide synthesis has its advantages and remaining chal-
lenges.20,42 One of its main advantages is shortening of the time
required for the synthesis; in about one day the process is
complete compared to manual synthesis, which can take days
and the final yield is much lower. Some of the problems associ-
ated with the widespread use of this method are: (i) the needed
excess of building blocks that are not commercially available and
their procurement constitutes the biggest time commitment for
carbohydrate assembly; (ii) difficult incorporation of certain
monosaccharides such as sialic acid; (iii) the cross-metathesis
reaction used to cleave the linker in many cases takes time as long
as the assembly process itself; (iv) the protective groups removal
usually requires several steps and good chemical skill.
Enzyme catalysed synthesis of oligosaccharides 43,44 is often
used as an alternative of the existing chemical methods. The main
advantage of enzymatic synthesis is that substrates are used in
their natural form, i.e. no protecting groups are required to direct
the regio- and stereo-specificity of the glycosidic bond formation.
Two types of natural enzymes that can be used in this process are
available, namely glycosyltransferases and glycosidases (Fig. 7).
Complex glycoconjugates such as glycopeptides, glycoproteins
and glycolipids have been synthesised through multiple-enzyme
processes with the help of enzymes as sulfotransferases, prote-
ases, lipases and aldolases (e.g. Table 3).
The use of enzyme-based synthesis implicates several restric-
tions.37,43–45 As already mentioned, glycosyltransferases are not
always readily available and thus expensive nucleotide-activated
glycosides are required. Glycosyltransferases from microbial
sources are a viable alternative as it has been demonstrated by the
synthesis of a range of oligosaccharide analogues.46,47 Glycosi-
dases are another alternative. In comparison with glycosyl-
transferases, they are inexpensive, stable and readily available.
Fig. 7 General protocols for glycosyltransferase (A,B) and glycosidase (C,D) based synthesis: addition of phosphatase (A); recycling of sugar
nucleotides (B); trans glycosylation (C) and reverse hydrolysis (D).
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Moreover, they use cheaper substrates, such as sugar halides
and p-nitrophenyl glycosides. Their main drawbacks are: poor
regiospecificity that can result in the formation of multiple
products; the typical lower yields owing to the challenge of
driving reactions in a thermodynamically unfavourable direction
and because of enzymatic degradation of the reaction products.
However, the Withers group found48,49 that mutagenesis of
glycosidases (replacement of a nucleophilic aspartic or glutamic
acid with another amino acid) produces an enzyme named as
‘‘glycosynthase’’ that can catalyse the synthesis of a saccharide
from a fluorosugar donor but does not catalyse the hydrolysis of
the resulting product. Although multi-enzymatic methods have
been developed and proved to be useful for a large-scale process
(Fig. 8), the identification of other enzymes with high activity and
broad substrate specificity remains a challenge in the synthesis of
glycans.
Carbohydrate arrays
Amajor challenge in TE is to define the interactions between cell-
coating sugars and different bioentities available in the extra-
cellular environment such as proteins, enzymes, RNA, cells,
pathogens and to understand how they recognise each other.51–53
A better understanding of these interactions would greatly aid to
the elucidation of different signalling pathways and thus, even-
tually lead to faster regeneration process as well as to improved
diagnostic and therapeutic tools. However, this is not an easy
task since the carbohydrate-bioentity interactions are often weak
(e.g. the affinity of GBPs for their glycan ligand is typically with
Kd ¼ 1–1000 mM53). Additional complications arise from the
fact that efficient binding relies on multivalent interactions
(cluster effect) that are very difficult to measure experimentally.54
Moreover, carbohydrate heterogeneity and the cross-reactivity
of sugar binding proteins require large number of carbohydrate
ligands to be screened.18,19 Microarray techniques offer the
Table 3 Enzymes commonly used in glycoconjugates synthesis
Enzyme family Role Enzyme
Glycosyltransferases Transfer of a carbohydrate from
the corresponding sugar
nucleotide donor substrate to
a specific hydroxyl group of the
acceptor sugar
Galactosyltransferases (GalT)
Sialyltransferases (SiaT)
Fucosyltransferases (FucT)
Mannosyltransferases (ManT)
N-Acetylhexosaminyltransferases
(GlcNAcT, GalNAcT)
Glucosyltransferases (GlcT,
GlcUAT)
Glycosidases exo-Glycosidases cleave the
glycosidic linkages during
glycoprotein synthesis in vivo.
Under controlled conditions can
be used to synthesise glycosidic
bonds; endo-Glycosidases cleave
internal glycosidic linkages and
can also catalysed trans-
glycosylation reactions.
Galactosidases
Sialidases
Fucosidases
Mannosidases
N-Acetylhexosaminidases
Glucosidases
Sulfotransferases Sulfation of hydroxyl groups from
oligosaccharide or peptide to
which it is attached
GlcNAc 6-sulfotransferase
Tyrosylprotein sulfotransferase
Proteases Formation of peptide bonds in
glycopeptides or selective
acylating agents
Subtilisin
Lipases Selective acylation or ester
hydrolysis at specific positions
on a glycoconjugates
particularly important for the
glycopeptides
Aldolases Formation of monosaccharides
and their derivatives via aldol
reaction (C–C bond)
d-2-Deoxyribose-5-phosphate
aldolase (DERA)
NeuAc aldolase
Fig. 8 Multiple enzyme system used in the large-scale synthesis of sLex.
The method has been extended to the synthesis of hyaluronic acid and it is
believed that all the oligosaccharides in mammalian systems can be
prepared by this methodology.50
This journal is ª The Royal Society of Chemistry 2010 J. Mater. Chem., 2010, 20, 8803–8818 | 8811
Do
wn
loa
de
d b
y U
niv
ers
ida
de
 do
 M
inh
o (
UM
inh
o) 
on
 11
 N
ov
em
be
r 2
01
0
Pu
bli
sh
ed
 on
 05
 O
cto
be
r 2
01
0 o
n h
ttp
://p
ub
s.r
sc.
org
 | d
oi:
10
.10
39
/C
0J
M
01
60
5E
View Online
possibility of high-throughput analysis of these interactions
using minimal quantities of sugar samples. In order to pro-
vide both satisfying selectivity and quantitative performance,
the carbohydrate arrays must fulfil several requirements55:
(i) carbohydrates must be present in a regular and homogeneous
manner so that all immobilised ligands have equal activity
toward the analytes present in the solution; (ii) the density of the
immobilised carbohydrates must be very well controlled because
many carbohydrate-analyte interactions are polyvalent in nature
and their affinity is extremely sensitive to the density and
orientation of individual carbohydrates19; (iii) a spacer between
the carbohydrate and the surfaces is needed to provide the ana-
lyte with access to the immobilised sugar; (iv) from practical
point of view it is very important that the array is compatible
with several detection methods (e.g. fluorescence, surface plas-
mon resonance, quartz crystal microbalance, etc.).
The first trials on and with carbohydrate arrays were inspired
from the protein, gene and cell chips. Several approaches for
polysaccharides and glycoconjugates microarrays56,57 using natural
and synthetic oligosaccharides58–60 and monosaccharides55,59–62
were reported in 2002 by different groups. Since then intensive
research has been carried out on different strategies for immobi-
lisation of natural and synthetic sugars on glass, plastic and gold
surfaces (Table 4). So far, no particular fabrication method has
emerged as a winning approach and therefore, new methods to
array carbohydrates are still under development.
The reported approaches differ primarily in the method of
attachment of carbohydrate to the solid support. So far, four
general strategies (Fig. 9) have been communicated in the liter-
ature: (i) non-specific, non-covalent immobilisation of unconju-
gated carbohydrates on unmodified surfaces; (ii) site-specific,
non-covalent immobilisation of conjugated carbohydrates on
unmodified surfaces; (iii) site-specific, covalent immobilisation of
conjugated carbohydrates on derivatised surfaces; and (iv) site-
specific, covalent immobilisation of chemically unmodified
carbohydrates on modified surfaces.
Strategies involving non-covalent immobilisation are related
to higher flexibility of the macromolecules on the supports and
thus with an easier alignment of the binding sites,71 although
these features are not proven experimentally. Their main
advantage is the possibility of a direct use (without any pre-
treatment or modification) of natural carbohydrates that are
simply deposited by physical adsorption on properly treated
surfaces. Usually modified microscope glass slides are used as
supports. However, other supports such as nitrocellulose,56,58
modified polystyrene,57 and polyvinylidene fluoride58 have been
also used as immobilisation platforms in different approaches.
The molecular weight of the used polysaccharides should be high
enough to guarantee sufficient immobilisation. Hence, oligo-
saccharides and monosaccharides cannot be densely and stably
immobilised at the surface if they are not coupled to another
larger moiety such as lipids58,59 or fluorous tags (C8F17).
61
Therefore, strategies involving covalent coupling are preferred
for immobilisation of simple carbohydrates and oligosaccharides
Table 4 Methods for attachment of glycans to the surface of microarray
Immobilisation strategy Surface Used glycan type Reference
Non-covalent immobilisation Nitrocellulose membranes Oligosaccharides 58
Polyvinylidene fluoride (PVDF) Oligosaccharides 58
Black polystyrene Polysaccharides 57
Glycoconjugates
Microtiter plates Monosaccharides 59,63
Oligosaccharides
Modified glass Nitrocellulose coated Dextrans 56
Fluorinated glass Monosaccharides 61
Poly-L-lysine coated Heparin polysaccharides 64
Semicarbazide modified Polysaccharides 65
Covalent coupling Polystyrene (microtiter) plates Monosaccharides 60,66
Oligosaccharides
Benzoquinone coated surface Monosaccharides 55
Modified glass Thiol modified glass Monosaccharides 62
Disaccharides
Phtalimide photoactive
chromophores
Monosaccharides 67,68
Oligosaccharides
Polysaccharides
Aminooxi- and hydrazide-modified
glass
Monosaccharides 69,70
Oligosaccharides
Polysaccharides
NHS activated glass Glycoconjugates 51
Fig. 9 Immobilisation strategies for carbohydrates on solid surfaces.
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(Fig. 10). Usually, these strategies require both chemically
modified glycans and derivatised surfaces. The role of the linkers
between the coupled glycan and the support must be stressed out
because they govern both binding of the protein and suppression
of the non-specific binding. In general, hydrophilic linkers (e.g.
PEG) have better binding properties for proteins. Their length
also influences the binding affinities: glycans linked by longer
tethers interact with proteins stronger than those connected
by shorter linkers do. Site-specific, covalent immobilisation
of chemically unmodified carbohydrates on modified surfaces
(Fig. 10D) is the best option for constructing glycoarrays. This
strategy avoids the use of functionalised sugars, which are typi-
cally prepared by multistep synthetic methods. A large number 58
of sugars with different size (monosaccharides, oligosaccharides
and polysaccharides) have been immobilised on aminooxy- or
hydrazide modified glass surfaces70,72 under different conditions
(temperature, time, pH and concentration). It has been observed
that carbohydrates immobilised on hydrazide surface exhibit
more intense signals after lectin binding than those immobilised
on aminooxy-coated slides. An alternative approach that does
not require modified sugars involves photo-induced covalent
attachment of carbohydrates to surfaces that are coated with
photoactive phtalimide derivatives.67,68 Upon exposure to light,
the grafted surface adsorbs the carbohydrates by hydrogen
abstraction followed by radical recombination. The immobili-
sation yield is much less dependent on the molecular weight of
the spotted carbohydrates and in fact, shows higher grafting
efficiency for lower molecular weight glycans.
Fig. 10 A schematic presentation of different strategies for covalent, site specific immobilisation of modified glycans on surfaces functionalised with
thiol groups (A), benzoquinone (B), amino groups (C), cyanur chloride (D), N-hydroxysuccinimide ester (E), epoxy groups (F), maleimide (G), alkyne
(H), aldehyde (I) and phosphane (J).
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The detection of the interactions is usually performed by
fluorescence where the dye is either directly attached to the
analyte or indirectly via a fluorescently marked labelling agent.18
Fluorescence-based methods are preferred not only because of
their high sensitivity but also because they are compatible with
various materials such as glass or gold. However, it must be
noted that this procedure often results in protein denaturation or
interference with carbohydrate ligand binding. Thus, detection
techniques that do not require protein labelling are necessary.
Surface plasmon resonance (SPR) spectroscopy55,73–77 and mass
spectrometry60,63,66,78–81 are options but they need to be adapted
and optimised to work properly in a high-throughput manner.
In spite of the technological differences mentioned above,
glycoarrays share a number of common advantages such as large
capacity, high detection sensitivity and long-lasting stability.
While the first two advantages are related with the use of
microarray platform, the third one is specific for carbohydrates;
most of them are stable at room temperature as dry powders.
Hence, the arrays produced from them can be kept at room
temperature for months or years without structural or immu-
nological changes.57,82 These arrays were proposed as an
advanced technology just few years ago but they have already
demonstrated their high potential in the TE and biomedical fields
(Fig. 11). Analysis of carbohydrate-bioentities interactions,
profiling of the specific binding of antibodies, elucidation on
carbohydrate-mediated cell recognition events, and detection of
pathogens for diagnosis are only some examples of important
glycoarrays applications.
Manipulation of cell surface glycans: carbohydrates as
third generation biomaterials
Analysis of glycosylation patterns of different cells and tissues
has shown that these patterns are controlled but they are not
genetically coded. This allows dynamic regulation of the overall
structure and shape of sugar molecules and makes the cell flexible
and able to respond quickly to change. In fact, our immune
system is based on that flexibility: many pathogens have glycan-
binding proteins (GBPs) that recognise host glycan structure as
receptors for attachment (Table 5). In turn, the eukaryotic
organisms have developed GBPs that recognise some pathogenic
glycans in the innate immune response. Carbohydrates are also
important for the development of tumours because cancer cells
alter the expression of glycoproteins at their cell surface in order
to evade the immune system. By covering themselves with the
right assortment of glycoproteins, the tumour cells can invade
other tissues without being identified as aliens.
Unfortunately, in this evolutionary war, the pathogens are still
winning. Thus, the necessity for the development of chemical
tools that block oligosaccharides and glycoconjugates forma-
tion and/or function has emerged. Two main types of inhibitors
have been established during the years:16 those that block gly-
coconjugates biosynthesis and those that interfere with glyco-
conjugates recognition. The first approach is based mainly on the
generation of antagonists of the biosynthetic and processing
enzymes. The discovery and development of sialidase inhibitors
in the fight against the influenza virus is an excellent example that
illustrates the applicability of this approach. Sialidase is an
exoglycohydrolase that cleaves a-ketosidically linked Neu5Ac
residues at the end of various glycoconjugates.83 Together with
M2 ion channel protein and the lectin haemagglutinin, this
enzyme decorates the surface of influenza virus A. In a typical
process, the virus adheres to the host cell using its haemag-
glutinin to recognise glycoconjugates that display terminal
a-sialic acid (Fig. 12) residues. The virus is then exocytosed and
fusion occurs. Subsequent synthesis of viral protein and particle
Fig. 11 Several applications of carbohydrate microarrays.
Table 5 Saccharide specificity for some pathogens and toxines.10
Pathogen/Virus Broad saccharide specificity
Escherichia coli
Type 1 pili Man(a1,3)Man(a1,6)Man
P Gal(a1,4)Gal
S NeuAc(a2,3)Gal(b1,3)GalNAc
CFA/1 NeuAc(a2,8)NeuAc
K99 NeuGc(a2,3)Gal(b1,4)Glc
Bordetella pertussis Gal(b1,4)Glc-ceramide
Neisseria gonorrheae Gal(b1,4)GalNAc
Foot and mouth virus Heparin sulfate
Avian influenza virus 2,3 linked sialic acids
Human influenza 2,6 linked sialic acids
Influenza C 9-O-acetyl sialic acids
Botulinum neurotoxins gangliosides GD1a, GD1b, GT1a
Shiga toxin 1 and 2 Gal(a1,4)Gal(b1,4)Glc-ceramide
(Gb3) and analogues
Pertussis toxin Sialic acid, Gal(b1,4)Glc-ceramide,
gangliosides
Cholera toxin and LT-I Ganglioside GM1
E. coli enterotoxin, LT-IIa Gangliosides GD1b, GD1a, GM1
Fig. 12 Chemical structures of a- and b-anomers of sialic acid and some
of the inhibitors developed by mimicking it.
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assembly prepares the virion progeny for the budding process to
exit the host cell. Sialidase cleaves the terminal a-NeuAc from
both the host cell surface and the newly synthesised virion
progeny glycoproteins. Thus, the sialidase plays at least two
critical roles in the life cycle of the virus: it assists the movement
of virus particles through the upper respiratory tract and it helps
the release of virion progeny from infected cells.
Initially, sialidase inhibitors have been developed mimicking
the structure of a-sialic acid. Although 2-deoxy-a-D-N-
acetylneuraminic acid (Fig. 12, 2-deoxy-a-NeuAc) did not reach
the market, this compound was very important in the studies
elucidating the enzymatic mechanism of sialidase.83,84 Based
on an understanding of the enzyme’s catalytic mechanism, the
first class drug 4-deoxy-4-guanidino-NeuAc2en (zanamivir) was
developed. Zanamivir was launched as an inhalted formulation
because of one of the main problems associated with the devel-
opment of carbohydrates therapeutics: their highly polar nature
that turns them into inactive and unstable when applied orally.
Thus, the following efforts have been focused toward the
development of sialidase inhibitors based on non-carbohydrate
templates. Cyclohexenes,85 cyclopentanes86 and pyrrolidines87
have been investigated as core templates. From these trials, the
most noteworthy has been the development of the first sialidase
inhibitor oseltamivir approved to be used orally. Another effort
to target glycosylation enzymes has been proposed by Glyco-
Design in the war against cancer.88 For several years, clinical
trials with swainsonine (GD039) have been ongoing. GD039 is
a competitive inhibitor of the Golgi enzyme a-mannosidase II
(aMII), which is involved in the processing of N-linked carbo-
hydrates of newly synthesized glycoproteins as they make their
way through the Golgi apparatus to the cell surface (Fig. 3). The
N-linked pathway mediated by aMII leads to the formation
of highly branched carbohydrate structures, which by binding
to Lectin-phytohemagglutinin (L-PHA) can be expressed in
different types of tumours. When the enzyme aMII is blocked by
swainsonine there is a reduction in L-PHA reactive carbohy-
drates on cell surfaces; a less aggressive metastatic phenotype;
a slower tumour growth; and an accumulation of ‘‘hybrid-type’’
carbohydrates on the cell surface.
Unnatural metabolic substrates are an alternative to the
enzyme inhibitors. They are able to intercept the carbohydrate
biosynthetic pathways.16,89,90 As obvious from Fig. 3, those
unnatural metabolic decoys will be active only if they are able to
cross the plasma membrane and enter the Golgi where the
assembling of the glycoconjugates occurs. Unfortunately, many
of the compounds tested so far lack activity in living cells, most
probably because their polarity and charge prevents their uptake.
Metabolic interference can generate several responses on the
cell surface schematically presented on Fig. 13. A reduction in the
amount of the glycoconjugates expressed by cells (Fig. 13A)
might occur if the metabolic decoy diverts the oligosaccharides
elaboration away from endogenous scaffold destined for the cell
surface.89 An example for this effect is the use of xylosides as
primers. More than 35 years ago, Okayama et al.91 found that
cells use b-D-xylopyranosides as primers for glycosaminoglycan
formation. Xylosides mimic the natural substrate; they act as
acceptors for b-1,4-galactosyltransferase and thus as primers that
divert the assembly process from the endogenous core proteins
and cause inhibition of proteoglycan formation. In general, cells
incubated with xylosides secrete large amounts of individual
glycosaminoglycan chains and accumulate proteoglycans con-
taining truncated chains. The success of b-D-xylosides in altering
proteoglycan biosynthesis suggested that other glycosides might
also act as primers (Table 6).
Alternatively, incorporation of unnatural substrates into the
cell surface glycoconjugates (Fig. 13B) can occur if the inhibitors
are designed to engage the biosynthetic pathway. This approach
has been applied in a strategy targeting alteration of the
expression of cell surface glycans on tumour cells.92,93 Tumour
cells express sialic acids that are usually tolerated by the immune
system. Tumour immunity can be generated in principle by
introducing unnatural sialic acid precursors whose metabolic
incorporation leads to the generation of unnatural sialic acid
epitopes (Fig. 14). Using this strategy, more immunoreactive
cells have been engineered by adjusting the R-group in the
mannosamine.93 Such unnatural epitopes can be used as
vaccines; tumour cells might be preferentially targeted by this
approach due to higher expression of sialic acids.
In a third situation, an incorporation of unnatural sugar
bearing reactive functional group or marker can lead to the
formation of glycan structure that can be further modified by
chemical reactions at the cell surface (Fig. 13C). An emerging
approach toward glycan visualisation, so-called ‘‘bioorthogonal
chemical reporter’’, is based on this response and it has been
proposed by Prescher and Bertozzi.94 This approach hinges on
Fig. 13 Modulating cell behaviour via unnatural sugars present in the
extracellular space.
Table 6 Glycoside primers with potential use in TE and the biosynthetic
pathways affected by them89
Glycoside Pathway affected
Xylb-OR Glycosaminoglycans and
glycolipids
Galb-OR; Galb4Xyl-OR Glycosaminoglycans
GalNAca-OR O-glycans found on glycoproteins
and mucins
GalNAcb-OR Polylactosamines
Peracetylated Galb4GlcNAcb-OR Lewis X
This journal is ª The Royal Society of Chemistry 2010 J. Mater. Chem., 2010, 20, 8803–8818 | 8815
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the selection of a reporter group that can be readily installed on
the monosaccharide substrates with minimal structural pertur-
bation since they must be then processed similarly to their native
counterpart and integrated into cellular glycans, i.e. the enzymes
involved in the installation process must tolerate the unnatural
motif. Hence, the fluorescein probes cannot be used in direct
modifications because of their large size. Organic azides have
been found to be ideal chemical reporters (Fig. 15); they are
small, metabolically stable, and essentially inert in biological
systems. Moreover, they fulfil the requirements for the further
covalent reaction with a probe bearing chemical moiety
(Fig. 13C): the chemical bond must be formed at physiological
environment and at the same time to remain stable and inert to
the surrounding biological milieu. All these requirements rose
from the targeted application: in vivo non-invasive imaging of
glycan expression on cell surface. Mice were injected with either
ManNAz or GalNAz (Fig. 15) for several days and then
administered a phosphine probe.95 After several hours, the
anticipated product was observed on splenocyte cell surfaces and
serum glycoproteins.
As already mentioned, the function of surface oligosaccharides
and glycoconjugates can be also be altered by interference of
glycoconjugates recognition. Two complimentary strategies can
be used to achieve this goal: the active centre of the natural
carbohydrate receptor can be blocked with a corresponding
antagonist or the carbohydrate presented on the cell surface can
be blocked by synthetic carbohydrate receptors.
In the quest of identification of different carbohydrate receptor
antagonists, the sialyl Lewsx tetrasaccharide (Fig. 16 – 1, sLex)
became a lead structure. sLex has important roles in regulating the
inflammatory processes and in cancer metastasis; it is a common
epitope of the physiological selectin ligands and it is recognised by
the three known selectins (E-, P- and L-selectin).50,96,97 Extensive
research has elucidated that the essential pharmacophores
required for binding to E- and L-selectins are all three hydroxyl
groups of fucose, the 2- and 6- hydroxyl groups of the galactose
and the carboxylate of the neuraaminic acid. The binding to
P-selectin is similar except that the 2- and 4-hydroxyl groups of
fucose are not involved critically.
After the establishment of the sLex functional groups impor-
tant for complexation, mimics of the tetrasaccharide have been
synthesised that are potent selectin antagonists. For example, the
compound 3 presented on Fig. 16 is about 5 fold more active at
blocking E-selectin than sLex.98
The design of synthetic carbohydrate receptors has been
inspired by the crystal structures of protein-carbohydrate
complexes and has seen considerable progress in the past few
years.99 The main difficulty in the development of artificial car-
bohydrate receptors arises from the fact that most of the oligo-
saccharides binding sites are relatively shallow and solvent
exposed. Thus, the interactions of a receptor with the hydroxyl
groups of a carbohydrate-derived substrate do not fundamen-
tally differ from interaction with water molecules. At least two
types of interactions are realised in the described biomimetic
sugar receptors: hydrogen bonding and C–H/p interactions
formed by a coplanar arrangement between the substrate and the
aromatic receptors subunits. Recent investigation in the Davis
group100 demonstrated that efficient and selective recognition of
Fig. 14 Boosting tumour reactivity by alternation of cell surface
glycans.
Fig. 15 Several azides are used as bioorthogonal chemical reporters:94
azido analogues of natural sugars (left column) are metabolised by cells
and converted to cell surface azido sialosides (right column).
Fig. 16 Sialyl Lewisx (1) and its functional groups, which are critical for
binding to the selectins together with two E-selectin antagonists
mimicking sLex structure (2 and 398).
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carbohydrates in water can indeed be realised by using the
designed by them receptor represented on Fig. 17. An issue,
which needs to be addressed further, is whether such receptors
exert a characteristic effect on cell adhesion phenomena.
Conclusions
In the fast developing field of glycomics, scientists seem to have
risen to the challenge, making several crucial technological
advances in the past few years and overcoming at least some of
the obstacles to the elucidation and further exploitation of the
‘‘sugar code’’. Arrays, natural glycan libraries and synthetic
chemistry are at the forefront of technology developments and
are supported by progress in the development of essential tools
for data handling, bioinformatics and molecular modelling of
glycans. A major promise of glycoscience is its potential to be
used to manipulate cell-bioentity communication and applied in
the development of tissue regeneration strategies and treatment
of different diseases. These approaches can also lead to progress
in the diagnosis and therapeutic products based on specific
carbohydrates. Further progress in decoding the glycome must
bring new insights into its myriad functions and producing
diverse advances in the TE arena. Glycoscience can gain more
attention and development in the future only if the glycoscientists
are working like the sugars they are studying – they must be
highly interactive between themselves in order to function well.
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